![15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images 15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images](https://media.gettyimages.com/id/632761614/fr/photo/jean-paul-clozel-co-founder-of-actelion-ltd-speaks-during-a-news-conference-to-announce-the.jpg?s=612x612&w=gi&k=20&c=ekW38B_gX6qu8fPyI3VT64aic9Zou2CL3446Bohs3ag=)
15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images
![Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut» Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»](https://img.luzernerzeitung.ch/2020/10/7/e90ae494-5e69-4931-bf85-725ef96a4b8a.jpeg?width=1360&height=764&fit=bounds&quality=75&auto=webp&crop=1969,1107,x0,y623)
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
![Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges](https://www.challenges.fr/assets/img/2018/04/11/cover-r4x3w1200-5acdf9bd5f246-img-4611.jpg)
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
![Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France](https://www.college-de-france.fr/sites/default/files/styles/1_1_header_portrait_s/public/media/portrait/2022-07/Jean-Paul-Clozel.jpg?h=f0d95172&itok=x-K2x58a)
Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France
![CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total](https://c8.alamy.com/comp/2PBXWWB/caption-addition-jean-paul-clozel-ceo-of-biopharmaceutical-company-actelion-speaks-during-a-press-conference-in-allschwil-switzerland-thursday-february-22-2007-actelion-announced-its-financial-results-for-the-full-year-2006-with-total-net-revenue-of-9457-million-swiss-francs-usd-7644-and-operating-expenses-of-6775-million-swiss-francs-usd-5476-the-company-reported-operating-income-of-2682-million-swiss-francs-usd-2168-and-a-net-income-of-2411-million-swiss-francs-usd-1949-keystonegeorgios-kefalas-2PBXWWB.jpg)
CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total
![15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images 15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images](https://media.gettyimages.com/id/632755468/fr/photo/paul-stoffels-chief-scientific-officer-of-johnson-johnson-left-jean-paul-clozel-co-founder-of.jpg?s=612x612&w=gi&k=20&c=r41gQy-nUDXHiOEQUrYU8pFpDp2TNdcCvpWqyUF9Tr0=)